Become a Member
Dark Mode
Become a Member
Members Only
Latest News
Special Projects
Neon
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
×
×
Coronavirus 2019
As Third Wave Ebbs, Centre Urges States, UTs To Relax COVID-19 Curbs
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
ADVERTISEMENT
COVID-19 Death Recount Takes February’s Fatality Numbers to a 7-Month High
COVID: India Records Slight Dip In Daily Cases With 25,920 New Infections
India Reports Over 30K New COVID Cases; Haryana Removes All COVID Restrictions
Delhi Reports 756 New COVID-19 Cases; Andhra Pradesh Lifts Night Curfew
Over 34K Fresh COVID-19 Cases in India, Death Toll Over 5.09 Lakh
Google To Cut Salaries, Eventually Fire Unvaccinated Employees
New York Declares State of Emergency Amid Threat of New COVID-19 Variant Omicron
India May Start Vaccinating Children in 12-14 Age Group in March: NTAGI Chief
Covaxin 50% Effective Against Delta Variant, Shows First Real-World Study
No Approval for Covaxin Yet, WHO Seeks Additional Clarification to Decide on EUL
As Third Wave Ebbs, Centre Urges States, UTs To Relax COVID-19 Curbs
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
COVID-19 Death Recount Takes February’s Fatality Numbers to a 7-Month High
COVID: India Records Slight Dip In Daily Cases With 25,920 New Infections
India Reports Over 30K New COVID Cases; Haryana Removes All COVID Restrictions
Delhi Reports 756 New COVID-19 Cases; Andhra Pradesh Lifts Night Curfew
ADVERTISEMENT
Over 34K Fresh COVID-19 Cases in India, Death Toll Over 5.09 Lakh
India May Start Vaccinating Children in 12-14 Age Group in March: NTAGI Chief
Google To Cut Salaries, Eventually Fire Unvaccinated Employees
New York Declares State of Emergency Amid Threat of New COVID-19 Variant Omicron
Covaxin 50% Effective Against Delta Variant, Shows First Real-World Study
No Approval for Covaxin Yet, WHO Seeks Additional Clarification to Decide on EUL
Load More
